This is groundbreaking, the whole issue with CV is there is no actual treatment at the moment except the vaccine which isn't fully functional, it also doesn't deal with future strains (which is why the booster shots etc are happening)
If BIT can make this work and they appear to be part of the way there, there is a VERY real chance this could become a TO target for big pharma.
Something like this alone should give us a $200-$300m market cap.
This is groundbreaking, the whole issue with CV is there is no...
-
- There are more pages in this discussion • 4,831 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
